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1Changing demographics is creating a larger population of people aged 60 year or over: the median age in Europe 
is the highest in the world, and the proportion of people aged 
65 years and older is forecast to increase from 14% in 2010 to 
28% in 2060.1 Even in the absence of clinical hypertension the 
aging process is associated with cardiovascular changes that 
impair arterial function leading to an increased risk of cardio-
vascular disease in this population group.2
Diet is a tractable modifier of vascular health and blood 
pressure (BP), and it has been shown that targeting the 
whole diet has synergistic and cumulative effects on BP 
over individual foods and nutrients.3 The most well-estab-
lished dietary interventions for the reduction in BP are the 
Dietary Approaches to Stop Hypertension (DASH) diet4 and 
the Mediterranean diet.5 Both of these dietary patterns have 
been shown to reduce BP in randomized controlled trials.4,6 
Adherence to the DASH diet for 8 weeks reduced systolic 
(SBP) and diastolic (DBP) BP by 5.5 and 3.0 mm Hg, respec-
tively, compared with a control diet.4 The Prevención con 
Dieta Mediterránea trial in patients at high cardiovascular 
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disease risk showed that a Mediterranean diet supplemented 
with olive oil or nuts reduced DBP by −1.5 mm Hg and −0.7 
mm Hg, respectively, in comparison to a low-fat diet over 4 
years.6
The Mediterranean diet is rich in fruits, vegetables, 
legumes, nuts, and olive oil, with moderate intakes of fish, 
dairy and wine, and low intakes of meat.5 In the current 
study, we developed a Mediterranean-style diet designed 
specifically to meet the dietary recommendations of people 
over 65 years of age.7 It follows the original Mediterranean 
diet in many aspects with high intakes of fruits, vegetables, 
legumes and olive oil, and moderate red wine. Unlike the tra-
ditional Mediterranean diet, the newly developed diet recom-
mends high intakes of whole grains, protein (from low-fat 
dairy, lean meat and fish), low intakes of sodium and vitamin 
D supplementation (10 µg/d), therefore, complying with the 
American Heart Association/American College of Cardiology 
guidelines for reducing cardiovascular risk and dietary recom-
mendations for older adults.8,9 It has been estimated that the 
traditional Mediterranean diet provides 1 serving of dairy, 0.5 
to 0.75 servings of meat and 4 servings of cereal (refined and 
wholegrain) and 2632 mg of sodium per day.10 This suggests 
the Mediterranean diet does not meet current dietary recom-
mendations for older adults and may, therefore, be inadequate 
for long-term health.9
The aim of the current study was to assess for the first time 
the effects of a Mediterranean-style dietary pattern, specifi-
cally designed according to the dietary recommendations of 
older adults aged over 65 years, on BP and arterial stiffness in 
a 1-year European wide randomized controlled trial.
Methods
An expanded methods section is available in the online-only Data 
Supplement.
The data that support the findings of this study are available from 
the corresponding author on reasonable request. The NU-AGE study 
(New Dietary Strategies Addressing the Specific Needs of Elderly 
Population for Healthy Aging in Europe) was a 1-year randomized 
controlled trial that aimed to assess the effects of a Mediterranean-
style dietary intervention on markers of inflammation and many pre-
defined secondary end points, including cardiovascular health. The 
trial was performed in 5 European centers (Bologna in Italy, Norwich 
in the United Kingdom, Wageningen in the Netherlands, Warsaw in 
Poland, and Clermont-Ferrand in France).7 A detailed description 
of the project has been reported previously.11 Ethical approval was 
provided by the Independent Ethics Committee of the Sant’Orsola-
Malpighi Hospital Bologna (Italy), the National Research Ethics 
Committee—East of England (United Kingdom), the Wageningen 
University Medical Ethics Committee (the Netherlands), the Bioethics 
Committee of the Polish National Food and Nutrition Institute 
(Poland), and South-East 6 Person Protection Committee (France). 
All participants provided written informed consent, and the study 
was conducted in accordance with the Declaration of Helsinki, Title 
45, US Code of Federal Regulations, Part 46, Protection of Human 
Subjects, Revised November 13, 2001, effective December 13, 2001, 
and institutional guidelines. The NU-AGE trial was registered.
Participants
Recruitment and selection criteria have been reported7 and are sum-
marized here. In total, 1294 participants aged 65 to 79 years were 
recruited through local advertisements, publicity, and general prac-
titioner registers between April 2012 and January 2014 at the 5 re-
cruitment centers. Study participants were free living and responsible 
for their own shopping, meal choices, and preparation. Exclusion 
criteria are outlined in the online-only Data Supplement. Participants 
were randomly allocated to the intervention or control group (1:1 
allocation ratio) after stratification by sex, age, frailty status (pre-
frail or nonfrail), and body mass index using a computer program. 
Participants were informed about their group allocation after base-
line measurements were collected; therefore, they were not blinded 
to treatment allocation at follow-up, and so were theoretically in a 
position to discuss this while undergoing measurements. Because of 
practical impossibilities, those conducting the measurements were 
not always blinded to treatment.
Dietary Intervention
Participants randomized to the intervention group received individ-
ually tailored standardized dietary advice to meet the study dietary 
requirements following evaluation of the baseline habitual diet using 
7-day food diaries. The dietary advice is outlined in Table S1 in the 
online-only Data Supplement and has been described previously.7 
This individually tailored dietary advice, either given face-to-face or 
by telephone by a trained dietician/research nutritionist, was admin-
istered 9 times during the year and supported by mail or email. To en-
hance compliance and meet the dietary guidelines, participants in the 
intervention group received commercially available foods including 
whole grain pasta, extra virgin olive oil, low-fat low-salt cheese, high 
polyunsaturated fat margarine, and vitamin D supplements (10 µg/d). 
Participants completed 3-day food diaries and returned unused vi-
tamin D supplements at months 4 and 8 to evaluate follow-up adher-
ence and use of the provided foods. Participants randomized to the 
control group were requested to continue with their usual diet for the 
year and provided with a generally available leaflet that outlined cur-
rent dietary guidance. Compliance to the study protocol in both the 
intervention and control groups was evaluated with 7-day food dia-
ries at the start and end of the 1-year intervention. A scoring system 
(NU-AGE index) was developed to measure adherence to the diet, 
full details are outlined in the online-only Data Supplement.
Outcome Assessment
At baseline and after 1-year office BP was measured using automated 
and calibrated electronic BP monitors. Trained nurses or researchers 
took the measurements following standardized procedures across all 
sites (in the online-only Data Supplement).
Directly preceding BP measurements, a 24-hour urine collec-
tion was obtained for estimation of sodium and potassium excretion. 
Participants with incomplete 24-hour urine collections based on ex-
pected creatinine excretion (mg/d) in relation to body weight (kg) 
were excluded (in the online-only Data Supplement).
The Vicorder device was used to measure both carotid-femoral 
pulse wave velocity (PWV) and augmentation index (AIx; Skidmore 
Medical, Bristol, United Kingdom)12 in a subset of participants (UK 
study center). Full experimental details are available in the online-
only Data Supplement. PWV is considered a gold standard measure-
ment for assessment of arterial stiffness.13 As arterial stiffening causes 
early return of the reflected wave and thereby augments central aortic 
pressure which cannot be evaluated by brachial cuff measurements, 
this makes PWV and AIx highly prognostic of cardiovascular risk.14 
Although the reflected wave originates predominantly at the major 
branches of the aorta, the stiffness of the smaller arteries and arteri-
oles has a considerable influence on the central pressure waveform.15 
It is, therefore, important to assess both direct measures of large arte-
rial stiffness (PWV) and markers of systemic arterial stiffness (AIx).
Statistical Analysis
The power calculation for the estimation of the required sample size 
for this trial was based on a change in CRP (C-reactive protein) of 
0.6 mg/L (SD 4), which indicated a sample size of 1000 participants 
(2-sided, 80% power, and 0.05 α). This number was increased to 
1250 to account for an anticipated dropout rate of 20%. Based on 
previous research suggesting dietary intervention reduced SBP by 
5.5 mm Hg (SD 8.2) compared with control our sample size gave us 
>99% power to detect changes (2-sided, 0.05 α).16 Arterial stiffness 
was only measured in the UK trial participants; previously published 
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sample size requirements suggest this sample size was adequate to 
detect clinically significant changes in AIx@75 of 9 units.17
Baseline characteristics were presented as mean±SD or n (%) for 
categorical variables, baseline between-group differences were as-
sessed using independent sample t tests or χ2 tests. The effect of the 
intervention on changes in BP, 24-hour urinary sodium and potassium 
and arterial stiffness were assessed using ANCOVA with treatment 
group as the predictor and baseline measure, study center, age, sex, 
baseline antihypertensive use, baseline body mass index, baseline 
smoking status, self-reported diabetes mellitus, and level of dietary 
compliance as covariates. We included a treatment group x sex in-
teraction term in the model for our primary outcome, SBP, to test if 
subgroup analysis was justified. To examine which components of 
the diet were driving potential intervention effects we also assessed 
change in dietary intake between the intervention and control groups 
using ANCOVA models, as previously described, after adjustment for 
study center, sex, age, and baseline body mass index. We repeated all 
our analyses excluding participants identified as outliers (< or >3 SD 
from mean), as the observed estimates were similar in both models 
(with and without outliers), we only present the results of the analysis 
in the complete data set. All analyses were performed using STATA 
(version 14; StataCorp, TX).
Results
Of the 1294 participants recruited to the NU-AGE study, 
n=1142 completed (11.7% drop out rate; (Figure 1). Of the 
participants who completed, n=14 (1.2%) were excluded 
because of missing data giving a final sample size of 1128 
(n=567 in control group and 561 in intervention group). There 
were no significant differences in baseline characteristics be-
tween the groups (Table 1). Forty-three percent of participants 
had hypertension, and 45% were taking antihypertensive 
medication; of these participants, 45% took multiple classes 
of medication, most commonly angiotensin-converting en-
zyme inhibitors (68%) or β blockers (42%; data not shown). 
At 1-year follow-up, 47% of participants (n=528; n=264 con-
trols; and n=264 intervention) were taking antihypertensive 
medication, 1.5% of participants had stopped (n=17; n=12 
control; and n=3 intervention), and 2.9% had started (n=33; 
n=20 control; and n=13 intervention).
The NU-AGE diet index did not change over the 1-year 
period in the control group (2.0 points, 95% CI, −0.2 to 4.4) 
but increased by 23.4 points (95% CI, 21.1–25.7) or 28.5% in 
the intervention group (between-group difference 21.4 points, 
95% CI, 19.5–23.3, P<0.001; data not shown). The change in 
score in the intervention group appeared to be driven by spe-
cific dietary components, notably increased intake of fruits, 
vegetables, legumes, nuts, fish, whole grains, and olive oil 
Figure 1. Flowchart of participants in the NU-
AGE trial (New Dietary Strategies Addressing 
the Specific Needs of Elderly Population for 
Healthy Aging in Europe).
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(Figure 2). Specifically, the greatest differences in change 
(expressed as a percentage of baseline intake) between the in-
tervention group and controls were observed for nuts (40%, 
P<0.01), legumes (65%, P<0.01), fish (35%, P<0.01), whole 
grains (79%, P<0.01), low-fat dairy (33%, P<0.01), olive oil 
(63%, P<0.01), and high sugar products (−21%, P<0.01). No 
significant differences between the groups were observed for 
intakes of lean meat and poultry (P=0.41) or alcohol (P=0.50).
There were significant between-group differences for 
change in SBP of −5.5 mm Hg (95% CI, −10.7 to −0.4, P=0.03) 
when all participants were examined together (Table 2), with a 
−4.7 mm Hg (95% CI, −7.8 to −1.5) decrease in the interven-
tion group and 0.9 mm Hg (95% CI, −2.2 to 4.1) increase in 
the control group at 1-year follow-up. There was a significant 
interaction effect for SBP between treatment group and sex 
(P=0.02) and when stratified by sex, the effect of the NU-AGE 
diet on SBP was observed for males (between-group differ-
ence −9.2 mm Hg; 95% CI, −17.3 to −1.2; P=0.02) but not 
females. The intervention also resulted in a decrease in pulse 
pressure in males (between-group difference −6.1 mm Hg; 
95% CI, −12.0 to −0.2; P=0.04). No significant effects of 
the intervention on DBP were evident. As shown in Figure 3 
there was a favorable intervention effect on SBP in both medi-
cated (n=512) and nonmedicated (n=616) subgroups although 
the effect was only significant in the nonmedicated group 
(between-group difference −8.5 mm Hg; 95% CI, −14.9 to 
−2.1; P=0.01).
The intervention also resulted in an increase in levels of 
24-hour urinary potassium concentrations (between-group dif-
ference 8.8 mmol/L; 95% CI, 0.7–16.9; P=0.03) and in males, 
a decrease in levels of 24-hour urinary sodium concentrations 
(between-group difference −27.1 mmol/L; 95% CI, −53.3 to 
−1.0; P=0.04; Table 2). We also observed differences in 24-hour 
urinary potassium excretion in all participants (between-group 
difference 12.4 mmol/24-hour; 95% CI, 3.2–21.7; P=0.01, 
data not shown) and in 24-hour urinary potassium and sodium 
excretion in males (potassium between-group difference 22.3 
mmol/24-hour; 95% CI, 7.7–37.0; P<0.01; sodium between-
group difference −53.9 mmol/24-hour; 95% CI, −105 to −2.9; 
P=0.04, data not shown).
For arterial stiffness, which was assessed only at the UK 
study center (n=225), we observed a significant improvement 
in AIx@75 with a change of −6.1 (95% CI, –12.5 to 0.3) in the 
intervention group and 6.3 (95% CI, 0.2 to 12.5) in the con-
trol group (between-group difference −12.4; 95% CI, −24.4 to 
−0.5; P=0.04). When stratified by sex this effect was observed 
for females (between-group difference −16.4; 95% CI, −32.2 
to −0.6; P=0.04) but not males. No impact of the intervention 
on PWV was observed (Figure 4).
Discussion
In this large 1-year multi-center randomized controlled 
trial, a Mediterranean-style dietary intervention resulted 
in clinically relevant improvements in robust measures of 
vascular health in apparently healthy older people aged 65 
to 79 years. Specifically, SBP was lowered by 5.5 mm Hg, 
and in a subset, we observed a significant improvement 
in AIx@75 of −12.4 (95% CI, −24.4 to −0.5; P=0.04). 
These data suggest that modest dietary change towards a 
Mediterranean-style dietary pattern has the potential to re-
duce cardiovascular risk. The reduction observed in SBP 
of −5.5 mm Hg would be predicted to reduce the risk of 
Table 1. Baseline Characteristics of the NU-AGE Study Participants According to Intervention Group
Variable Intervention Diet Control Diet P Value
Sex, female n=561 318 (56.7) n=567 307 (54.1) 0.39
Age, y n=561 70.7±4.0 n=567 71.0±3.9 0.13
Smoking history, yes n=561 301 (53.7) n=567 302 (53.3) 0.99
Body mass index, kg/m2 n=561 26.7±4.1 n=567 26.6±3.7 0.75
Diabetes mellitus, yes n=561 28 (5.0) n=567 25 (4.4) 0.64
Hypertension, yes n=561 330 (58.8) n=567 317 (55.9) 0.32
Antihypertensive therapy, yes n=561 256 (45.6) n=567 256 (45.1) 0.87
Systolic blood pressure, mm Hg n=561 137±19.5 n=567 138±19.8 0.48
Diastolic blood pressure, mm Hg n=561 75.1±9.8 n=567 75.6±10.6 0.43
Pulse pressure, mm Hg n=561 62.3±15.1 n=567 62.6±15.1 0.71
24-h urinary potassium, mmol/L n=407 41.8 (19.4) n=424 40.7 (18.4) 0.38
24-h urinary potassium, mmol/24-h n=407 75.1 (32.2) n=424 75.6 (42.0) 0.84
24-h urinary sodium, mmol/L n=407 80.5 (47.6) n=424 78.5 (40.3) 0.51
24-h urinary sodium, mmol/24-h n=407 142.1 (66.3) n=424 143.1 (64.8) 0.82
Pulse wave velocity, m/s n=115 9.0±1.6 n=122 9.4±1.8 0.07
Augmentation index n=114 25.8±20.6 n=116 24.8±19.3 0.70
Dietary compliance score n=561 82.2 (15.4) n=567 82.1 (16.3) 0.93
Values are mean±SD or n (%). P value for difference between intervention and control groups (independent sample t tests or χ2 tests). NU-AGE 
indicates New Dietary Strategies Addressing the Specific Needs of Elderly Population for Healthy Aging in Europe.
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mortality from stroke by 14%, from coronary heart disease 
by 9%, and all-cause mortality by 7%.18 Although we also 
observed a between-group difference of −1.7 mm Hg (95% 
CI, −4.3 to 0.9) in DBP this finding did not reach statistical 
significance. This magnitude of change in DBP, however, 
compares to those observed in the Prevención con Dieta 
Mediterránea study in 7447 participants followed-up over 
4 years, for a Mediterranean diet supplemented with either 
olive oil (−1.53 mm Hg) or nuts (−0.65 mm Hg).6
There is growing evidence that in older adults SBP is a 
more robust cardiovascular disease risk factor than DBP and 
therapeutic strategies that specifically target SBP are recom-
mended for older adults as aging is associated with structural 
and functional changes in the vascular wall that increase ar-
terial stiffness and SBP.19 Although in a subset we observed 
a significant improvement in AIx@75 (−12.4) we did not 
observe any change in PWV. There are mechanistic expla-
nations for why the intervention reduced SBP and AIx but 
not PWV. Elevated BP accelerates conduit artery stiffness, 
measured by AIx, but not aortic stiffness, assessed by PWV.20 
Furthermore, pharmacological studies have shown that a re-
duction in SBP leads to alterations in the vascular tone of 
small muscular arteries and not the elastic aorta, which influ-
ences reflected wave intensity and, hence, AIx independently 
of PWV.21,22 However, the relationship between BP and arte-
rial stiffness is bidirectional and aortic stiffening (measured 
by AIx and PWV) increases pressure pulsatility and, there-
fore, affects SBP.20
To our knowledge, only the beef in an optimal lean diet 
clinical trial in 36 normotensive individuals has examined the 
impact of the DASH diet on vascular measures beyond BP, 
including AIx.23 In parallel to our findings, this short-term 
study (5 weeks) reported that the DASH diet and a DASH-
like diet containing lean meat was associated with reductions 
in AIx (not adjusted to heart rate) of 13.6±3.3 and 10.4±3.0, 
respectively, when compared with a healthy control diet. A 
Mediterranean diet has shown to improve endothelial func-
tion compared with a habitual control diet in 2 studies, first 
in 152 normotensive older adults over 6 months (measured by 
flow-mediated dilation) and second in 180 adults with meta-
bolic syndrome after 2 years (measured by peripheral artery 
tonometry).24,25
We found sex differences in response to the intervention, 
with the effect on SBP and pulse pressure only being appar-
ent in males and, hence, we observed an intervention effect 
on arterial stiffness, but not peripheral BP, in females. These 
results are consistent with findings from a case-control study 
that reported that consumption of a Mediterranean diet dif-
ferentially affected coronary risk in males and females26 and 
with a short-term (4 week) intervention which observed a re-
duction SBP following a Mediterranean-style diet in males 
only.27 Differences in arterial structure and function between 
males and females provide a plausible biological mechanism 
to support these findings. Specifically, peripherally measured 
BP has shown to underestimate central SBP in females mak-
ing assessing central rather than peripheral BP more clinically 
Figure 2. Percentage change in key dietary components of the Mediterranean-style diet after 1 y of follow-up in the intervention and control diet groups. 
Bars represent means adjusted for study center, age, sex, and body mass index (BMI). * indicates a significant difference between intervention and control 
groups (P<0.05, ANCOVA).
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relevant.28 Furthermore, sodium and potassium supplementa-
tion have been shown to effect BP with no concomitant effect 
on AI.29 We observed an effect of the intervention on 24-hour 
urinary sodium and potassium in males but not females, 
demonstrating that the dietary intervention resulted in a lower 
intake of sodium and higher intake of potassium in males but 
not in females. There were also differences in response to 
the intervention by location with the reduction in SBP only 
Table 2. Mean Difference in Blood Pressure and 24-Hour Urinary Sodium and Potassium After 1 Year of Follow-Up in the Intervention and Control Diet Groups
Sex Variable Intervention Diet Control Diet Group Difference P Value
All Systolic pressure, mm Hg n=561 −4.7 (−7.8, −1.5) n=567 0.9 (−2.2, 4.1) −5.5 (−10.7, −0.4) 0.03
Diastolic pressure, mm Hg n=561 −2.4 (−4.0, −0.8) n=567 −0.6 (−2.2, 0.9) −1.7 (−4.3, 0.9) 0.19
Pulse pressure, mm Hg n=561 −2.0 (−4.4,0.4) n=567 1.3 (−1.1, 3.6) −3.3 (−7.1, 0.6) 0.10
24-h urinary potassium, mmol/L n=407 3.6 (−0.7, 7.9) n=424 −5.2 (−9.3, −1.1) 8.8 (0.7, 16.9) 0.03
24-h urinary sodium, mmol/L n=407 −8.6 (−16.1, −1.1) n=424 −3.1 (−10.3, 4.1) −5.5 (−19.6, 8.6) 0.45
Males Systolic pressure, mm Hg n=243 −7.2 (−12.1, −2.3) n=260 2.0 (−2.7, 6.7) −9.2 (−17.3, −1.2) 0.02
Diastolic pressure, mm Hg n=243 −3.2 (−5.7, −0.6) n=260 −0.2 (−2.7, 2.2) −2.9 (−7.1, 1.3) 0.18
Pulse pressure, mm Hg n=243 −3.9 (−7.5, −0.2) n=260 2.1 (−1.4, 5.6) −6.1 (−12.0, −0.2) 0.04
24-h urinary potassium, mmol/L n=178 7.5 (1.1, 14.0) n=200 −10.1 (−15.9, -4.3) 17.7 (5.8, 29.6) 0.00
24-h urinary sodium, mmol/L n=178 −23.7 (−37.9, −9.4) n=200 3.5 (−9.3, 16.2) −27.1 (−53.3, −1.0) 0.04
Females Systolic pressure, mm Hg n=318 −3.0 (−7.2, 1.1) n=307 0.3 (−4.0, 4.5) −3.1 (−9.8, 3.6) 0.37
Diastolic pressure, mm Hg n=318 −2.1 (−4.1, 0.0) n=307 −0.6 (−2.7, 1.4) −1.4 (−4.7, 1.9) 0.41
Pulse pressure, mm Hg n=318 −1.1 (−4.3, 2.1) n=307 1.1 (−2.2, 4.3) −2.0 (−7.1, 3.2) 0.45
24-h urinary potassium, mmol/L n=229 1.2 (−4.6, 7.0) n=224 −1.5 (−7.4, 4.4) 2.7 (−8.4, 13.9) 0.63
24-h urinary sodium, mmol/L n=229 0.1 (−8.1, 8.3) n=224 −5.9 (−14.3, 2.4) 6.0 (−9.8, 21.9) 0.45
Values are mean (95% CI). Models adjusted for baseline measure, study center, age, sex, baseline antihypertensive use, baseline BMI, baseline smoking status, self-
reported diabetes mellitus, and level of dietary compliance. P value for difference between intervention and control groups (ANCOVA). BMI indicates body mass index.
Figure 3. Mean difference in systolic blood pressure after 1 y of follow-up in the intervention and control diet groups stratified by baseline antihypertensive 
use. Bars represent mean (95% CI) adjusted for baseline measure, age, sex, baseline body mass index (BMI), baseline smoking status, self-reported diabetes 
mellitus, and level of dietary compliance in participants using antihypertensive medications (A) and participants not using antihypertensive medications (B). P 
value for difference between intervention and control groups (ANCOVA).
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apparent in Mediterranean countries (−8.8 mm Hg; 95% CI, 
−17.3 to −0.3; P=0.04) and the effect on potassium evident 
only in non-Mediterranean countries (9.2 mmol/L; 95% CI, 
0.4–18.1; P=0.04).
To our knowledge, no previous studies have evaluated 
the effect of a Mediterranean-style diet, specifically mod-
ified to meet the dietary recommendations of older adults 
on cardiovascular health. The key differences between the 
Mediterranean-style diet developed as part of the NU-AGE 
project and a traditional Mediterranean diet were the emphasis 
on high intakes of whole grains, and protein (from dairy and 
lean meat), low-sodium intakes and vitamin D supplemen-
tation. Wholegrain and protein intakes have both been as-
sociated with lower BP.30,31 Furthermore, there is increasing 
evidence that circulating vitamin D levels are related to inci-
dent hypertension with a 12% lower risk for each 10 ng/mL 
increment in circulating 25-hydroxyvitamin D.32 In the current 
study, we observed a 4.5 ng/mL (95% CI, 3.9–5.1) increase 
in circulating 25-hydroxyvitamin D in the intervention group 
compared with 0.5 mg/mL (95% CI, −0.1–1.0) in controls 
(data not shown). The Mediterranean-style diet specified lean 
meat intake as one strategy to increase protein intake among 
older adults, alongside increased intakes of fish, nuts, and 
low-fat dairy. Although some evidence indicates that red meat 
intake is associated with chronic disease risk it is generally ac-
cepted that unprocessed meats do not increase sodium intakes 
and display no correlation with high BP.33 Interestingly, results 
from the current study indicated that participants in the in-
tervention group significantly increased intakes of fish, nuts, 
and low-fat diary and not lean meat intake and, therefore, the 
intervention did not adversely affect sodium intake or 24-hour 
sodium excretion.
The current study has a number of strengths including the 
randomized design, the large sample size and the relatively 
long duration of the study. Our participants were recruited 
from several Mediterranean and non-Mediterranean coun-
tries, which increases the generalisability of our findings. 
Furthermore, we took a pragmatic approach and did not ex-
clude participants with hypertension or using antihypertensive 
medications, resulting in wide translatability to a European 
older adult population. Although parameters of arterial stiff-
ness were only measured in a subset of the total cohort in 
one study center this is one of the largest randomized con-
trol trials to examine the impact of a Mediterranean-style diet 
on these outcomes. There are also a number of limitations. 
Cardiovascular health was not the primary end point of the 
trial but was included in the protocol as a key secondary out-
come, in addition, arterial stiffness was only measured in one 
study center, meaning the significance of the results are lim-
ited and need to be confirmed in future studies. As this was a 
pragmatic trial dietary compliance varied, however, we were 
able to control for this by including the level of compliance as 
a covariate in our analyses. Several different BP devices were 
used for participants, although the same device was used per 
individual to measure BP at baseline and follow-up. While we 
also standardized the body position used when measuring BP 
at both time points (seated) we acknowledge that supine or 
standing readings may have given different values.
Figure 4. Mean difference in arterial stiffness after 1 y of follow-up in the intervention and control diet groups in the UK study center. Bars represent mean 
(95% CI) adjusted for baseline measure, age, sex, baseline antihypertensive use, baseline body mass index (BMI), baseline smoking status, self-reported 
diabetes mellitus, and level of dietary compliance for pulse wave velocity (A) and Augmentation Index (B). P value for difference between intervention and 
control groups (ANCOVA).D
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In conclusion, a Mediterranean-style diet specifically tai-
lored to meet the dietary recommendations of older adults is 
effective in improving cardiovascular health with clinically 
relevant reductions in BP and arterial stiffness observed. 
These results suggest variability in cardiovascular response to 
the Mediterranean diet between males and females that merits 
further investigation in future clinical trials.
Perspectives
These data suggest that modest dietary change towards a 
Mediterranean-style dietary pattern has the potential for clin-
ically relevant improvements in SBP and systemic arterial 
stiffness, measured by augmentation index. We found sex dif-
ferences in response to the intervention, with an effect on SBP 
in males and arterial stiffness in females. We propose this may 
be because of the effect of the intervention on 24-hour urinary 
sodium and potassium in males but not females.
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What Is New?
•	A Mediterranean-style dietary pattern resulted in a significant reduction 
in systolic blood pressure and augmentation index, a measure of arterial 
stiffness, and an increase in 24-hour urinary potassium.
•	 In sex-stratified analyses, the effect on blood pressure was only apparent 
in males, and there was an intervention effect on arterial stiffness, but 
not peripheral blood pressure, in females.
What Is Relevant?
•	There was variability in cardiovascular response to the Mediterranean 
diet between males and females which merits further investigation in 
future clinical trials.
Summary
A Mediterranean-style diet is effective in improving cardiovascular 
health in older adults with clinically relevant reductions in blood 
pressure and arterial stiffness observed.
Novelty and Significance
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